These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 17709954

  • 21. Lessons from multiple sclerosis: models, concepts, observations.
    Wekerle H.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii56-60. PubMed ID: 19022815
    [Abstract] [Full Text] [Related]

  • 22. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L, Zamvil SS.
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [Abstract] [Full Text] [Related]

  • 23. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.
    Sriram S, Steiner I.
    Ann Neurol; 2005 Dec; 58(6):939-45. PubMed ID: 16315280
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New insights into adaptive immunity in chronic neuroinflammation.
    Siffrin V, Brandt AU, Herz J, Zipp F.
    Adv Immunol; 2007 Dec; 96():1-40. PubMed ID: 17981203
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P.
    Neurodegener Dis; 2008 Dec; 5(1):8-15. PubMed ID: 18075269
    [Abstract] [Full Text] [Related]

  • 33. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 34. Hormonal factors in susceptibility to multiple sclerosis.
    Duquette P, Girard M.
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):195-201. PubMed ID: 8481563
    [Abstract] [Full Text] [Related]

  • 35. The complex etiology of multiple sclerosis.
    Winquist RJ, Kwong A, Ramachandran R, Jain J.
    Biochem Pharmacol; 2007 Nov 01; 74(9):1321-9. PubMed ID: 17537409
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul 01; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA, Millward JM, Owens T.
    J Neuroimmunol; 2007 Nov 01; 191(1-2):79-85. PubMed ID: 17920696
    [Abstract] [Full Text] [Related]

  • 40. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C.
    Inflammopharmacology; 2007 Oct 01; 15(5):183-7. PubMed ID: 17943249
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.